Abstract. Many epidemiological studies have reported the link between magnesium deficiency and metabolic syndrome. We examined whether magnesium deficiency in rats induces changes in glucocorticoid metabolism. Twelve-weekold, female Wistar rats were weaned onto a very low-magnesium diet or a control diet for two weeks. Quantitative real-time PCR was used to assess mRNA for 11␤ hydroxysteroid dehydrogenase-1 (11␤-HSD1), 11␤-HSD2, phosphoenolpyruvate carboxykinase (PEPCK), peroxisome proliferator-activated receptor ␣ (PPAR␣), and glucocorticoid receptor in the liver. Concentrations of adiponectin, leptin, corticosterone, insulin and asymmetric dimethylarginine (ADMA) in fasting serum were determined using a rat-specific enzyme-linked immunosorbent assay. After two weeks, no differences in serum glucose, leptin, corticosterone, or adiponectin levels were observed between the groups. Magnesium-deficient rats showed higher HOMA-IR, insulin, ionized calcium, ADMA levels and diastolic blood pressure. There were no significant differences in hepatic mRNA expression levels of GR, 11␤-HSD1, 11␤-HSD2, or PPAR␣ between the groups. We observed lower expression of hepatic PEPCK mRNA, in the magnesium-deficient rats, thus suggesting a possible compensatory mechanism to diminish glycogenesis. A low-magnesium diet alters glucocorticoid metabolism, which leads to endothelial damage. Higher ADMA induces hypertension and insulin resistance. Hyperinsulinemia induces hepatic downregulation of PEPCK, and is possibly a key mechanism inducing the metabolic complications of magnesium deficiency.
Introduction
Magnesium (Mg) is an essential mineral and has been established as a cofactor for over 300 metabolic reactions in the body. Lower intake a Takaya J and Kaneko K designed the research, Iharada A, and Okihana H conducted research. All authors read and approved the final manuscript.
of Mg and lower serum Mg concentrations are associated with and may lead to metabolic syndrome, insulin resistance and/or type 2 diabetes mellitus [1, 2] . Epidemiological studies have reported a link between Mg intake and insulin resistance in obesity and metabolic syndrome [3] ; however, the mechanisms behind this are poorly understood. Hypomagnesemia is a common complication of uncontrolled diabetes mellitus (DM) [4, 5] . Three patho-physiological doi:10.1684/mrh.2012.0321 mechanisms can induce Mg deficiency: reduced intestinal absorption, increased urinary loss, or intracellular shift of this cation. It has long been known that there is Mg deficit and increased renal Mg excretion in DM patients [5] .
In addition, preliminary data suggest that circulating cortisol concentrations are higher in patients with metabolic syndrome compared to healthy subjects [6] [7] [8] . Dysregulation of glucocorticoid action has been proposed to be one of the central features of metabolic syndrome [9] . In the major metabolic organs, tissue sensitivity and exposure to glucocorticoids are determined by the density of intracellular glucocorticoid receptors (GR) and the activity of the microsomal enzyme 11␤-hydroxysteroid dehydrogenase type 1 (11␤-HSD1) [10] . 11␤-HSD1 converts inactive glucocorticoids (cortisone in humans, 11-dehydrocorticosterone in rodents) to their active forms (cortisol and corticosterone, respectively) [11] . 11␤-HSD1 is highly expressed in liver and adipose tissue where glucocorticoids reduce insulin sensitivity and action [10] [11] [12] . Activity of 11␤-HSD1 in liver and adipose tissue might contribute to the development of several features of insulin resistance or metabolic syndrome. 11␤-HSD1 regulates the key hepatic gluconeogenic enzymes including phosphoenolpyruvate carboxykinase (PEPCK) (EC4.1.1.32) through the amplification of GR-mediated, tissue glucocorticoid action [11] [12] [13] . PEPCK simultaneously decarboxylates and phosphorylates oxaloacetate into phosphoenolpyruvate, one of the earliest, rate-limiting steps in gluconeogenesis [14] . PEPCK expression is dominantly inhibited by glucose-induced increases in insulin secretion upon feeding [15] .
We hypothesized that an Mg-deficient diet induces insulin resistance by upregulation of glucocorticoid activity in liver. In the present study, we examined whether Mg deficiency in rats induces changes in glucocorticoid metabolism.
Methods and materials

Animals and experimental design
Twelve-week-old, female Wistar Rats were used in the present study. Wistar rats were obtained from Shimizu Laboratories (Kyoto, Japan). All rats were maintained on a 12-hour light/12-hour dark cycle. Rats were randomly divided into two groups of 10 animals each and fed the respective diets for a period of two weeks ad libitum. Control group animals were fed a control diet (0.082% magnesium) based on the AIN93G formulation [16] . The low magnesium (low-Mg) group was fed an Mg-deficient diet (0.003% magnesium). Experimental diets were prepared in the laboratory on a weekly basis; diet compositions are presented in table 1. Rats were fed loose pellets in small metal dishes and were allowed free access to water. Blood pressure and heart rate of conscious rats were measured by the tail-cuff method using a blood pressure monitor (Model MK-2000, Muromachi Kikai Co., Ltd., Tokyo, Japan). The rats were decapitated with a guillotine and blood samples were taken from the trunk after a 12-hr fast. Kansai Medical University animal care facility approved all the experiments, which were performed in accordance with NIH guidelines for the use of experimental animals.
Measurement of biochemical parameters
Serum hormones levels
Whole blood was collected from the low-Mg and control group rats. Serum was separated by centrifugation. Serum insulin and corticosterone levels were detected using rat-specific ELISA kits (Morinaga, Yokohama, Japan) and the Rat Corticosterone Enzyme Immunoassay (EIA) Kit (Yanaihara Inc., Shizuoka, Japan), respectively. The lower limit of detection was 0.1 ng/mL for insulin and 0.21 ng/mL for corticosterone. Serum intact parathyroid hormone (PTH) levels were detected using the Rat intact PTH enzyme-linked immunosorbent assay (ELISA) Kit (Immutopics Inc., San Clemente, CA, USA). The lower limit of detection was 1.6 pg/mL.
Serum adipokines, glucose, asymmetrical dimethylarginine levels and lipid parameters
Concentrations of leptin were determined in fasting serum using rat-specific ELISA kits (Morinaga, Yokohama, Japan). The lower limit of detection was 0.4 ng/mL. Concentrations of adiponectin were determined in fasting serum using rat-specific ELISA kits (Otsuka Pharmaceutical, Tokyo, Japan). The lower limit of detection was 0.25 ng/mL for adiponectin. Concentrations of asymmetrical dimethylarginine (ADMA) were determined in fasting serum using rodent-specific ELISA kit (Immundiagnostic AG, Bensheim, German). The lower limit of detection was 0.05 mol/L for ADMA. Glucose concentrations were measured using a glucose oxidase system (Arkray, Kyoto, Japan). The homeostasis model assessment of insulin resistance (HOMA-IR) is the product of fasting plasma glucose (mM) and insulin concentrations (ng/mL) divided by 22.5 × 0.0417, and was used as a measure of insulin resistance [17] . The concentrations of serum total cholesterol, triglyceride, and high density lipoprotein-cholesterol (HDL-C) were determined using an enzymatic kit (Wako Co., Ltd., Tokyo, Japan).
Serum ionized magnesium and calcium levels
Serum ionized magnesium and calcium levels were measured with an automatic ion-selective electrode analyzer, Nova CRT 8 (Stat Profile Ultra M1, NOVA, Newton, MA, USA). The analyzer provides results for ionized Mg (measurement range of 0.1-2.5 mmol/L) and ionized calcium (Ca) (measurement range of 0.10-2.70 mmol/L).
Serum and urine nitrate/nitrite levels
The serum and urine nitrite (NO 2 -)/nitrate (NO 3 -) levels were measured using the colorimetric assay kit (Wako Pure Chemical Industries, Tokyo, Japan). Before measuring, samples were centrifuged through Micron YM-10 Centrifugal Filters (Micropore, Bedford, MA) to remove proteins from the serum.
mRNA isolation and quantification mRNA expression of hepatic genes was measured by real-time PCR. Briefly, total RNA was isolated from tissues using the RNeasy Mini Kit (QIAGEN Science, Germantown, MD, USA) according to the manufacturer's instructions, and was quantified spectrophotometrically at OD260. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the endogenous reference to normalize the transcript levels.
Amplification of mRNA by real-time PCR was performed in a total volume of 25 L with One
Step SYBR PrimeScript RT-PCR Kit II (Takara Bio Inc., Tokyo, Japan), as described by the manufacturer. Amplification using 35 cycles of 2 steps (95
• C for 15 s and 60
• C for 1 min) was performed on Real-time PCR Opticon 2 (MJ Japan, Tokyo, Japan). To confirm the amplification of specific transcripts, melting curve profiles were produced at the end of each run. The mRNA was quantified by the relative standard curve methods, and the relative amount of the respective mRNAs was normalized to the values of GAPDH. Table 2 shows primers and probes used in the PCR reactions.
Statistical analyses
Statistical analysis was performed using JMP 6 (SAS Institute Inc., Cary, NC,USA) software. Results are expressed as the mean ± standard error (SE). Statistically significant differences among the groups were determined by subjecting the data to the Mann-Whitney U test. Differences were considered statistically significant at P<0.05.
Results
Influence of dietary magnesium on blood pressure and body weight
After two weeks on the specific diets, mean diastolic, mean blood pressure and heart rate were increased in the low-Mg group as compared to the the control group (table 3) . No significant differences were observed in body weight or systolic blood pressure between the groups.
Serum biochemical levels
There were no effects on fasting glucose in the lowMg group rats, however, compared with the control group, fasting insulin (P<0.01) and HOMA-IR were significantly increased in the low-Mg group (P<0.05), indicating insulin resistance (table 4). Table 2 . Primer sequences used for the measurement of mRNA expression by real-time RT-PCR.
Gene
Forward primer Reverse primer 11␤-HSD1  TCATAGACACAGAAACAGCTTTGAAA  CTCCAGGGCGCATTCCT  11␤-HSD2  GCAGACCGATTTGTTGTTGA  GTGGATATCATCGTGGAAGAGAG  PPAR␣  CGGCAGCAGTGGAAGAATCG  TGGCAGCAGTGGAAGAATCG  PEPCK  AGCTGCATAATGGTCTGG  GAACCTGGCGTTGAATGC  GR  TGTATCCCACAGACCAAAGCA  AATCCTCATTCGTGTTCCCTTC  GAPDH  GGCACAGTCAAGGCTGAGAATG  ATGGTGGTGAAGACGCCAGTA HSD, hydroxysteroid dehydrogenase; PPAR␣, peroxisome proliferator-activated receptor ␣; PEPCK, phosphoenolpyruvate carboxykinase; GR, glucocorticoid receptor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Table 3 . Blood pressure and body weight of the Wistar rats given a standard diet (control) or lowmagnesium diet (low-Mg) in baseline and 2 weeks after.
Control
Low-Mg
55 ± 24 60 ± 22 54 ± 20 79 ± 4* Heart rate (beat/min) 410 ± 30 440 ± 6 420 ± 30 500 ± 8**
The values are means ± SE (control n = 10, low-Mg n = 10). The significance of differences between groups was analyzed using the Mann-Whitney U test. *p<0.05 **p<0.01. Mg, magnesium; Ca, calcium; PTH, parathyroid hormone; ADMA, asymmetric dimethylarginine; the values are means ± SE (control n = 10, low-Mg n = 10). The significance of differences between groups was analyzed using the Mann-Whitney U test. * p<0.05, ** p<0.01. The values are means ± SE (control n = 10, low-Mg n = 10). Mg: magnesium, Ca: calcium, P: phosphorus, Cr: creatinine. The significance of differences between groups was analyzed using the Mann-Whitney U test. * p<0.05, ** p<0.01.
No significant differences in serum levels of corticosterone, leptin and adiponectin were observed between the groups. Even though the low-Mg group had lower ionized Mg and higher ionized Ca levels, intact PTH levels were comparable between both groups. Serum phosphorus (P) levels were lower in the low-Mg group (table 4) . Serum triglyceride and total cholesterol levels were significantly higher in the low-Mg group, while HDL-cholesterol levels were comparable between both groups. Although serum NO 2 /NO 3 (NOx) levels were compatible, serum levels of ADMA in the low-Mg group were higher than the control group (table 4) .
Effects of low Mg on urine biochemical data
After two weeks on the specific diets, there were no significant differences in Ca/creatinine (Cr) between the two groups, while Mg/Cr was lower and P/Cr was higher in the low-Mg group than the control group. No significant differences in urine NO 2 /Cr, NO 3 /Cr, protein/Cr and glucose/Cr levels were observed between the groups (table 5).
Effects of low Mg on hepatic glucocorticoid-inducible gene expression
To examine the effect of a low-Mg diet on hepatic, local glucocorticoid action, expression of mRNAs encoding the liver-specific glucocorticoid-inducible genes was quantified. PEPCK mRNA expression was significantly reduced in the low-Mg group. GR, PPAR␣, 11␤-HSD1 and 11␤-HSD2 mRNA expression levels showed a similar tendency, yet without significant inter-group differences (table 6).
Discussion
In this study, we found that a two-week, Mgdeficient diet in rats was associated with acute changes in insulin resistance, and down-regulated hepatic expression of PEPCK mRNA. There were no significant differences in hepatic mRNA expression levels of GR, 11␤-HSD1, 11␤-HSD2, or PPAR␣ between the groups. PEPCK expression is induced by glucagons, catecholamines, and glucocorticoids during periods of fasting and in response to stress, but is dominantly inhibited by glucose-induced increases in insulin secretion upon feeding [15] . The direct inhibitory effect of insulin on the transcription and activity of key hepatic gluconeogenic enzymes through forkhead box class O-1(FOXO1) phosphorylation, including PEPCK [18] [19] [20] , is well established. Decreased expression of PEPCK induces decreased rates of hepatic gluconeogenesis. In metabolic syndrome, glucocorticoids up-regulate PEPCK gene expression in hepatocytes via a cyclic AMPdependent pathway [21] . Corticosterone-mediated up-regulation of hepatic gluconeogenesis involves a direct stimulation of hepatic PEPCK expression, which is caused by binding of GR to regulatory regions within the PEPCK promoter [22] . In our low-Mg rats, fasting plasma insulin concentrations were higher, but glucose concentrations were normal. Hepatic PEPCK was not activated by glucocorticoids, but mainly inhibited by insulin. The decrease in PEPCK mRNA expression occurred with hyperinsulinemia, while the animals did not develop overt features of diabetes. There are no significant modifications of RNA levels of genes except hepatic down-regulation of PEPCK. Hepatic down-regulation of PEPCK is possibly a key mechanism in the metabolic syndrome of Mg deficiency. Low Mg status has been associated with numerous pathological conditions characterized as having a chronic inflammatory stress component. Investigations of animal and cellular Table 6 . mRNA levels of each gene in the liver of Wistar rats given a standard diet (control) or low magnesium diet (low-Mg).
Group
11␤-HSD1 11␤-HSD2 PEPCK GR PPAR␣ Control 100 ± 7 100 ± 15 100 ± 14 100 ± 12 100 ± 10 Low-Mg 110 ± 20 120 ± 20 7 ± 2*** 90 ± 10 110 ± 22 HSD, hydroxysteroid dehydrogenase; PEPCK, phosphoenolpyruvate carboxykinase; GR, glucocorticoid receptor; PPAR␣, peroxisome proliferator-activated receptor ␣.
The values are means ± SE (control n = 10, low-Mg n = 10). The significance of differences between groups was analyzed using the Mann-Whitney U test. *** p<0.001.
responses to Mg deficiency have found evidence of complex proinflammatory pathways [23, 24] . Feingold et al. reported that inflammation inhibits the expression of PEPCK in liver [25] . Thus, inflammation in response to Mg deficiency may affect the low expression of PEPCK. A decreased insulin:glucagon ratio was reported in Mg-deficient rats [26] . Mg deficiency may alter PEPCK activity by affecting secretion of pancreatic hormones. The mean heart rate correlated significantly with the mean serum insulin levels. Insulin stimulates autonomic nervous system tone. In this model, an increase in sympathetic tone under hyperinsulinemia may increase heart rate in the low-Mg rats. HOMA-IR was significantly increased in the low-Mg group, indicating insulin resistance. The mechanism, by which Mg deficiency induces insulin resistance, is not clear. Data by Steinberg et al. [27] underlined the important role of eNO as a potential mechanism responsible for linking insulin action and vasodilation. An intriguing relationship has been demonstrated between insulin resistance and endogeneous NO synthase inhibitor ADMA plasma concentrations [28] . We found that serum ADMA levels increased in the low-Mg group, while the serum NO 2 -/NO 3 -levels were compatible. In the low-Mg group, total serum cholesterol and triglyceride were also higher than those in the control group. Inflammation occurring during experimental Mg deficiency is the mechanism that induces dyslipidemia or endothelial dysfunction [29] . Elevated endogenous ADMA may be implicated in hyperlipidemia-induced endothelial dysfunction and macroangiopathy [30] . Increased concentrations of ADMA may play a role in the development of insulin resistance [31] and hypertension [32] .
The decrease in insulin sensitivity is not appropriately compensated for by beta-cell function in human adult subjects with hypomagnesemia [33] . Mg is essential for insulin action, since it is a cofactor of tyrosine kinase activity [34] . Mg depletion may contribute to a post-receptor insulin resistance. Altered intracellular Mg also leads to decreased cellular glucose utilization and thus promotes peripheral insulin resistance with a post-receptor mechanism [35] . However, Corica et al. reported the close relationship between serum ionized Mg and intracellular free Mg concentrations [36] .
We investigated the notion that the low-Mg group had increased ionized Ca with no difference in intact PTH. Hypercalcemia, rather than hypocalcemia, has been observed in conjunction with severe Mg depletion in rat [37] , in contrast to the development of hypocalcemia in Mg deficiency in various other animal models. Hypercalcemia occurs in association with a decrease in serum phosphorus (P) levels in Mg deficiency. However, 5/6-nephrectomized uremic model, Mg-deficient rats show hypocalcemia rather than hypercalcemia [37] . An increase in serum PTH is induced by Mg depletion itself, in addition to serum Ca regulation effect. In this study, serum PTH levels are not suppressed despite the occurrence of hypercalcemia. PTH may be an important factor for the development of hypercalcemia correlated with phosphate metabolism.
It has long been known that there is a Mg deficit and increased renal Mg excretion in DM. Hypomagnesemia is a common complication of uncontrolled DM [4, 5] . Of the factors contributing to hypomagnesemia, renal Mg loss is the major determinant [5] . Hypomagnesemia in diabetic patients has been considered to be the result of hypermagnesuria. Net tubular reabsorption of Mg is decreased in diabetic patients in the presence of hyperglycemia, leading to hypermagnesuria and hypomagnesemia [4] . It has been previously reported that insulin can induce Mg excretion and lead to hypomagnesemia in patients with hyperinsulinemic states [38] . In this study, the Mg-deficient diet induced hyperinsulinemia prior to increased renal Mg excretion, while urinary phosphorus excretion increased. Mg stimulates renal phosphate reabsorption [39] . Changes in renal phosphate reabsorption are associated with modulation of the sodium-dependent phosphate cotransporter type IIa (NaPi-IIa) and type IIc (NaPi-IIc) protein, abundant in the brush-border membrane of proximal tubule cells [40] . NaPi-IIa is mainly regulated by dietary phospate intake and PTH. Under a high-Mg diet, NaPi-IIa expression is dependent on PTH levels, whereas NaPi-IIc expression seems to be independent of PTH levels [39] . In the Mg-deficient rats, the serum P levels decreased because urine P/Cr increased. Renal phosphate excretion is another mechanism that may be involved. Further studies are needed to determine the effect of PTH on proximal tubular pH and ion absorption under various physiological conditions.
The results of several, observational prospective studies have shown a relationship between low/insufficient oral Mg intake and the incidence of type 2 DM [2] or metabolic syndrome [41] . Food habits, such as low Mg intake, often become established during early stages of life. In conclusion, a low-Mg diet alters glucocorticoid metabolism, which leads to hepatic down-regulation of PEPCK, and is possibly a key mechanism for inducing the insulin resistance of Mg deficiency. Conflict of interest: none.
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